Chemours Company (NYSE:CC) shares, rose in value, with the stock price up by 1.07% to the previous day’s close as strong demand from buyers drove the stock to $27.32.
Actively observing the price movement in the last trading, the stock closed the session at $27.03. Referring to stock’s 52-week performance, its high was $39.05, and the low was $15.10. On the whole, CC has fluctuated by -5.40% over the past month.
The company’s Forward Dividend Ratio is 1.00, with its dividend yield at 3.66%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 5.88B, with a low estimate of 1.33B and a high estimate of 1.36B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.35B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CC’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of CC currently trading nearly 1.07% and 2.25% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.34, while the 7-day volatility ratio is showing 3.04% which for the 30-day chart, stands at 4.26%. Furthermore, Chemours Company (CC)’s beta value is 1.99, and its average true range (ATR) is 1.09.
A comparison of Chemours Company (CC) with its peers suggests the former has fared considerably weaker in the market. CC showed an intraday change of 1.07% in last session, and over the past year, it grew by 0.04%%.
Data on historical trading for Chemours Company (NYSE:CC) indicates that the trading volumes over the past 3 months, they’ve averaged 2.05 million. According to company’s latest data on outstanding shares, there are 148.59 million shares outstanding.
Nearly 1.20% of Chemours Company’s shares belong to company insiders and institutional investors own 74.76% of the company’s shares. The stock has fallen by -13.38% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CC stock heading into the next quarter.
